Target intelligence / Profile preview

CD2 antigen (CD2)

Target
CD2
Molecular classification
Cell surface glycoprotein, Receptor, Adhesion molecule
01

Overview

CD2 antigen is a transmembrane cell surface glycoprotein predominantly expressed on all peripheral blood T cells, thymocytes, and natural killer (NK) cells. It functions as a costimulatory receptor that binds to its ligand LFA3 (CD58), which is widely expressed on various cell types including antigen-presenting cells. The primary roles of CD2 include facilitating adhesion between T cells and other immune cells, organizing the immunological synapse during immune responses, and enhancing signal transduction required for full activation of memory and effector T cells. Its expression is upregulated upon activation or in memory subsets. Clinically, CD2 serves as a pan–T cell marker useful in diagnosing lymphoid malignancies such as T-cell lymphoma. Therapeutically, it has been targeted by monoclonal antibodies to modulate undesired immune responses—such as in transplantation or autoimmune disease—though this approach carries risks related to global suppression of cellular immunity.

Other names
T-cell surface antigen CD2LFA-2LFA-3 receptorT11/Leu-5p50
02

Mechanism of action

Immune modulation via inhibition or activation of T cell function through blockade or engagement of the CD2/LFA3 pathway

03

Biological functions

Immune responseSignal transductionCell adhesion
04

Disease associations

Cancer (notably T-cell lymphoma)Inflammation
05

Safety considerations

Risk of immunosuppression and infection due to broad targeting of T cells with anti-CD2 therapies
06

Interacting drugs

Anti-CD2 monoclonal antibodies (e.g., siplizumab)
07

Biomarkers

Marker for T-cell lineage in immunohistochemistry and diagnosis of T-cell lymphomas

Beyond the preview

Go deeper on CD2 antigen (CD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD2 antigen (CD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call